Abdominal Obesity Treatment Market Size, Share, Growth, Trends, and Forecast 2017 - 2025

"The Report Abdominal Obesity Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

Abdominal obesity or central obesity is medical condition in which excessive fat has built up around the abdomen and stomach to that it may have a negative impact on the human health. An individual is abdominally obese if the size of their waist is more than 90 cm in males and over 84 cm in females.

The major commercially available drugs used for the treatment of abdominal obesity are as follows:

Orlistat
Lorcaserin
Phentermine-topiramate
Methamphetamine
Phentermine
Phendimetrazine
Benzphetamine
Diethylpropion
Liraglutide

Other alternative regimens used for the treatment of abdominal obesity are as follows:

Bariatric surgery
Dietary therapy
Appetite suppressants
Physical exercise

Get Sample Copy Of This Report @ https://www.marketresearchreports.biz/sample/sample/1376066

It has been observed that unhealthy lifestyle practice and over consumption of fast foods are the major causes of abdominal obesity among population. In terms of geography, North America is the largest market for abdominal obesity treatment market due to the large base of obese patients. According to the WHO, the prevalence of obesity and overweight in the regions of the Americas is the highest followed by Europe and Eastern Mediterranean regions. Moreover, according to the Centers for Disease Control and Prevention (CDC), approximately 35% of the adult population of the U.S. is obese. However, other regions such as South East Asia, Middle East and Latin America are some of the potential market where introduction of effective novel therapies might boosts up the overall market growth of abdominal obesity treatment. Due to the significant rise in obesity and rising awareness among population, these regions are expected to be the lucrative market venture for abdominal obesity treatment.

The primary factors driving the growth of this market are increasing base of population suffering from obesity and increasing levels of awareness amongst weight conscious population. Moreover, development of safe and effective therapeutics for the treatment of abdominal obesity might contribute to the growth of the abdominal obesity treatment market. For instance, a novel anti-obesity therapeutic, Bupropion/zonisamide (planned brand name Empatic) is an investigational combination therapeutic for obesity treatment. The drug is currently at phase IIB clinical trial and is being developed by California, the U.S. based, Orexigen Therapeutics, Inc. The drug has successfully demonstrated positive trial results compared to placebo and monotherapies. Thus, the introduction of promising drugs in this market is likely to boosts the overall abdominal obesity treatment market due to the high success and effectiveness rate of the potential molecules. Furthermore, increasing government support for developing novel therapies along with high research and development initiatives on the development of personalized medicines are also expected to fuel the growth of this market. In addition, technological breakthrough such as minimally invasive surgical devices and increased focus on retaining superior quality of life are some of the factors that might contribute to the growth of this market. However, rise in overall healthcare expenditure and side effects of the anti-obesity drugs are some of the market-restraining factors that might hinder the growth of the abdominal obesity treatment market in the near future.

View Report @ https://www.marketresearchreports.biz/reports/1376066/abdominal-obesity-treatment-global-market-research-reports

Currently, the abdominal obesity treatment market is a highly attractive and promising market venture due to the high incidence rate of obesity among population. Various pharmaceutical and biotechnology companies are trying to develop novel therapeutics, which can be used for the treatment of abdominal obesity. Some of the companies involved with the development and commercialization of therapeutic products for treating abdominal obesity are Arena Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Novo Nordisk A/S, Orexigen Therapeutics, Inc., Upsher-Smith Laboratories Inc. and Vivus, Inc., amongst others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

Market segments and sub-segments
Market trends and dynamics
Supply and demand
Market size
Current trends/opportunities/challenges
Competitive landscape
Technological breakthroughs
Value chain and stakeholder analysis

The regional analysis covers:

North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)

Send An Enquiry Request @
https://www.marketresearchreports.biz/sample/enquiry/1376066

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

A complete backdrop analysis, which includes an assessment of the parent market
Important changes in market dynamics
Market segmentation up to the second or third level
Historical, current, and projected size of the market from the standpoint of both value and volume
Reporting and evaluation of recent industry developments
Market shares and strategies of key players
Emerging niche segments and regional markets
An objective assessment of the trajectory of the market
Recommendations to companies for strengthening their foothold in the market

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

State Tower 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-621-2074 USA: Canada Toll Free: 866-997-4948

This release was published on openPR.